Mahachai Hospital Public Co. Ltd.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. carries a market capitalization of 2.98B, placing it among publicly traded companies globally. Its enterprise value stands at 10.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. has 160.00M shares outstanding.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. trades at a trailing price-to-earnings ratio of 18.24. The price-to-sales ratio is 0.45, and the price-to-book ratio stands at 1.33.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. trades at an EV/EBITDA multiple of 8.82 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.53 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 20.21 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Mahachai Hospital Public Co. Ltd. trades at an EV/FCF ratio of 9.84, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 10.12B versus a market cap of 2.98B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 193.91, indicating elevated leverage, while an interest coverage ratio of 3.86 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Mahachai Hospital Public Co. Ltd. posted a return on equity (ROE) of 7.44, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 3.84 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.48, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.57, useful for judging operating efficiency across full business cycles. The company generates approximately 1.83M in revenue per employee across its workforce of 3,603.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 29.07 indicates how many times Mahachai Hospital Public Co. Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Mahachai Hospital Public Co. Ltd. recorded 65.35M in income tax expense. That works out to an effective tax rate of 25.08, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 260.54M, leaving 163.15M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Mahachai Hospital Public Co. Ltd.'s stock has declined approximately 11.65% over the past 52 weeks. The 50-day moving average sits at 18.83, while the 200-day moving average is 19.59.

Over the twelve months ended June 30, 2026, Mahachai Hospital Public Co. Ltd. generated 6.60B in revenue and converted that into 163.15M in net income, yielding earnings per share of 1.22. EBITDA reached 1.15B, while operating income came in at 500.70M.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. holds 254.89M in cash and equivalents against 6.36B in total debt, resulting in a net debt position of 4.63B. Total book value stands at 2.24B, with working capital of -1.14B providing operational flexibility.

Mahachai Hospital Public Co. Ltd. produced 958.76M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -153.22M in capital expenditures, free cash flow totaled 805.54M - equivalent to 5.03 per share.

Over the twelve months ended June 30, 2026, Mahachai Hospital Public Co. Ltd. posted a gross margin of 20.17, reflecting its pricing power and cost economics. The operating margin of 7.59 and net profit margin of 2.47 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Mahachai Hospital Public Co. Ltd. paid dividends of 0.00 per share. The dividend payout ratio of -0.08 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 27.07, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 28.00, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Mahachai Hospital Public Co. Ltd. shareholders.

Mahachai Hospital Public Co. Ltd.'s most recent stock split took place on September 11, 2023 with a 1:10 split ratio.

As of June 30, 2026, Mahachai Hospital Public Co. Ltd. has an Altman Z-Score of 1.16, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.